From the Journals

Concerning rise of staphylococcal scalded skin syndrome has U.S. doctors on alert


 

FROM THE BRITISH JOURNAL OF DERMATOLOGY

The rate of staphylococcal scalded skin syndrome (SSSS) appears to be on the rise among children in the United States, according to analysis of the Nationwide Inpatient Sample.

Alanna Staiman of Northwestern University, Chicago, and her associates evaluated 6,149,864 pediatric admissions from between 2008 and 2012 included in the Nationwide Inpatient Sample, and they identified 589 hospitalizations with a diagnosis of SSSS. They found that the SSSS annual incidence rate among U.S. children was 7.67 cases per million (Br J Dermatol. 2017 Oct 27. doi: 10.1111/bjd.16097). The estimated annual incidence rate was higher among children younger than 2 years of age at 45.1 cases per million, with a rate of 20.9 cases per million in children aged 1 year.

CDC/Janice Haney Carr
“Rates of SSSS significantly increased in the years 2010-2011 and 2012,” compared with 2008-2009, the researchers said.

There were several factors associated with SSSS, including the state of residence, time of year, and sex of the patient. In particular, patients in Midwestern and Southern states experienced the highest rates of SSSS. The times of year associated with the highest rates of SSSS were summer and autumn. Female children also experienced higher rates of SSSS than their male counterparts. Conversely, those who were of certain racial backgrounds and had a certain socioeconomic status had lower rates of SSSS, including patients who were black, whose families were in the second quartile of household incomes, whose families had public insurance, and those who had more chronic conditions.

The cost and length of stay (LOS) for SSSS was not insignificant; the investigators noted that these were more pronounced among black patients possibly because darker skin pigments might mask erythema and therefore delay diagnosis. Patients with SSSS can expect to have greater LOS than those without (3.2 vs. 2.4 days, respectively) and incur higher hospital costs ($4,624 vs. $1,872).

“The adjusted in-hospital mortality of SSSS was low (0.33%)” in this study, said Ms. Staiman and her associates. They added that this was consistent with findings in other studies.

There were several comorbidities frequently associated with SSSS. These included skin infections, cellulitis, pharyngitis, upper respiratory tract infection, and other respiratory infections. Patients diagnosed with SSSS also were likely to have a fungal or viral infection.

Courtesy RegionalDerm.com

Perioral involvement is seen in a child with staphylococcal scalded skin syndrome (SSSS)

“SSSS poses a significant health care burden, with increased LOS and costs of care per hospitalization and increasing prevalence over the 2008-2012 study period” the investigators wrote. Future work must be done to further understand how to reduce SSSS, they added.

The researchers had no conflicts of interest. Funding for the study was provided by a grant from the Agency for Healthcare Research and Quality and from the Dermatology Foundation.

Recommended Reading

Up-to-date vaccination status varies by mother’s country of origin
MDedge Family Medicine
IGRA preferred test for latent TB diagnosis
MDedge Family Medicine
PCV13 vaccination safe, effective in 6- to 17-year-olds
MDedge Family Medicine
Use of MenACWY-CRM vaccine in 2- to 10-year-olds raised no safety concerns
MDedge Family Medicine
VIDEO: New herpes zoster vaccine may boost vaccination rate
MDedge Family Medicine
Young adult HIV patients may be at increased risk of hypertension
MDedge Family Medicine
Methotrexate holiday linked to better flu vaccine immunogenicity
MDedge Family Medicine
Immunization information systems show progress over recent years
MDedge Family Medicine
Public health hazard: Bring your flu to work day
MDedge Family Medicine
Pregnant women’s access to vaccination website, social media improved infants’ up-to-date immunizations
MDedge Family Medicine